Dr. Derry K Mercer is currently Honorary Professor, School of Pharmacy and Life Sciences, Robert Gordon University, Aberdeen. He was a biological scientist and obtained his B.Sc (Hons) in 1990 and his Ph.D in 1994, both from the University of Liverpool in Microbiology. He has worked in scientific research, predominantly as a microbiologist. He has also worked for a number of years on connective tissue and associated diseases, with a special interest in the role of collagen deposition in cardiovascular disease. His microbiology research in academia has involved the enzymes of actinomycetes, genetically-modified microorganisms in gut ecosystems and polysaccharide-degrading enzymes from gut microorganisms. His main areas of expertise are microbiology, molecular biology and drug development. In 1995 he moved from academia to a senior position with a specialist biotechnology company, NovaBiotics Ltd, developing novel antimicrobials for the treatment of bacterial and fungal infections. He has a significant interest in scientific policy and he is a member of the Biochemical Society Policy Committee. As a part of his work, he collaborates closely with a number of universities and was made Honorary Professor by Robert Gordon University as a result of his ongoing collaborations with them. He was a Fellow of both the Royal Society of Medicine and the Society of Biology.
Microbiology; Molecular biology; Drug development; Enzymes of actinomycetes; Genetically-modified microorganisms in gut ecosystems and polysaccharide-degrading enzymes from gut microorganisms.